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INTRODUCTION
Hemophilia A is a hemorrhagic trend almost 
exclusively affecting males (X-related recessive 
disease). In 85% of cases, it is caused by factor 
VIII deficiency, called hemophilia A or classic 
hemophilia.1  Diagnosis of hemophilia is usually 
suspected when bleeding symptoms occur sponta-
neously or after trauma.2 Preoperative preparations, 
careful intubations and invasive tools administra-
tion, and the readiness of blood factor transfusions 
may play an important role in managing patients 
with hemophilia in anesthesia. 
CASE REPORT
An 11 years old boy, 30 kg, presented with a lump 
on his left fifth finger since eight months prior to 
admission. Previously about one month before, he 
was playing soccer and when he fell to the ground 
the finger was stepped by his friend. The lump was 
getting bigger in size, but with no such pain in the 
area. The finger’s joint movement is limited. He was 
diagnosed with pseudo cyst and planned for open 
biopsy with frozen section. 
During lab exams for surgery, his APTT level 
was unmeasurable, despite normal PT and bleed-
ing time. Upon consultation to pediatrician, he 
was found to have history of bruises in multiple 
 occasions, sometimes without any history of 
trauma. A similar history in the family could not be 
evaluated since he was adopted. He was diagnosed 
with Hemophilia A and planned for cryoprecipitate 
transfusion and Koate-DVI, an intravenous anti- 
hemophilic factor. Prior to surgery, his hemoglobin 
level was 11.9 g/dL, and his hemostasis factors were 
PT 11,9 (13,1), APTT 61,2 (34,1), and INR 1,03. 
He was planned for general inhalational anesthe-
sia with ETT insertion. He was pre-medicated with 
Midazolam 1 mg. Medications used were Propofol 
50 mg, Fentanyl 50 mcg, and Atracurium 15 mg. 
Intubation was conducted carefully and gently, 
avoiding excessive trauma to the airway. He was 
maintained under anesthesia by oxygen, nitrous 
oxide, and sevoflurane. Cryoprecipitate and PRCs 
were ready to use and available on-site. 
Surgery was uneventful, lasted for 120 minutes. 
Pseudo cyst was removed. Bleeding was 100 mL, 
no blood components were used during surgery. 
Post-surgery he was transferred to intermediate 
ward, and received another dose of Koate-DVI. 
Continuous drip of fentanyl and IV paracetamol 
were prescribed for analgetics. He was discharged 
from hospital 5 days after the surgery. 
DISCUSSION
Hemophilia A, a recessive X-linked disorder involv-
ing lack of functional clotting factor VIII (FVIII), 
represents 80% of hemophilia cases. Severe cases 
(<2% functional factor VIII) have spontaneous 
bleeding. Moderate (2-10% functional factor VIII) 
and mild (>10%) lead to excessive bleeding only 
after trauma or surgery. Patients have high APTT 
but platelet count, bleeding time and prothrombin 
time are normal. Factor assay is diagnostic.3  
A multidisciplinary team has to be involved 
when patients with hemophilia are planned 
for surgery.4 The knowledge related to replace-
ment therapy should be mastered not only by 
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Hemophilia presents challenging consideration for anesthesiologists. In 
non emergency cases it is essential that factor VIII is raised to its optimal 
activity prior to surgery. Intra operative bleeding is a fatal complication in 
hemophilia. Certain measurements must be taken under considerations 
to manage this case for anesthesia. Peripheral lines should be secured 
with utmost care. Intramuscular injections and arterial punctures must 
be avoided. Intubation and airway positioning should be done gently in 
deep plane anesthesia. Small vessels hemostatis must be taken care of by 
the surgeon. A multidisciplinary team has to be involved when patients 
with hemophilia are planned for surgery. The knowledge related to 
replacement therapy should be mastered not only by hematologist, but 
also by the whole team involved in patient management. 
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hematologist, but also by the whole team involved 
in patient management.5
In preparing patients with hemophilia A for 
surgery, factor VIII levels are routinely raised to 
approach 100% of normal activity. It should be 
maintained for the first 3 postoperative days, from 
the day 4 onwards it should be maintained at 80%, 
from 7th day onwards it is allowed to decline to 
40% of normal activity. The formula used to calcu-
late the factor VIII dose is: 
N = plasma volume (ml/kg) × weight (kg) × 
Percent activity increase
where N is the number of units required. Plasma 
volume is 40 ml/kg for adults. Since half-life of 
factor VIII is about 12 hours, it must be adminis-
tered twice daily. Cryoprecipitate is next choice of 
blood product in the management of hemophilia A, 
which provides 80 units of factor VIII per bag.6 
All the patients with hemophilia, regardless of its 
severity, are at risk of excessive bleeding during and 
after surgery. Intramuscular premedication should 
be avoided.1,6 Vascular access itself does not cause 
excessive bleeding and should be appropriate for 
the proposed procedure.1 Avoid arterial puncture 
whenever possible. 
Extra care should be taken in intubation it can 
cause submucosal hemorrhages, which can turn 
the situation to a life-threatening one. Nasal intu-
bation should be avoided as it can prove traumatic 
and bleeding from the site can lead to aspiration.1,6 
Intubation should be done in deep plane of anes-
thesia.7 Care should be taken during positioning 
of the extremities, and pressure points should be 
padded to prevent intramuscular hematomas or 
hemarthrosis.1,5,6,7 
Hypertension and tachycardia during surgery 
in hemophiliacs can lead to increased surgical 
bleeding. Controlled hypotension techniques 
prevent hemostasis of small vessels but are not 
recommended. Hemodynamic conditions should 
be maintained near normal.1 Suctioning the airway 
must be gentle to avoid unnecessary trauma to the 
airway and oral cavity. Use of both NSAID and 
steroids for should be avoided due to its potential to 
cause gastrointestinal bleeding. 
Surgeon should give special attention to small 
vessel hemostasis, rather than trusting on hemo-
static physiological mechanisms. The patient was 
taken up for surgery at the earliest after the APTT 
was normalized or optimized. The  availability of 
sufficient quantities of clotting factor concentrates 
was ensured before undertaking the surgery.1 
Postoperative PICU or intermediate room is 
mandatory to monitor the signs and symptoms of 
intracranial hemorrhage. Postoperative monitoring 
for bleeding was done with Hb and AT levels along 
with factor VIII assay.1,7
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